GSK endows research chair at Univ of Manitoba

Guest Contributor
November 30, 2008

GlaxoSmithKline (GSK) is contributing $1 million to the Univ of Manitoba to establish an endowment for a research chair in the immunobiology of infectious disease. The funds will be used to establish the chair and recruit a top researcher as chairholder. The GSK endowment is part of the company's $22-million initiative — Pathfinders Fund for Leaders in Canadian Health Science Research. Previous contributions from the fund include $1.75 million to the Univ of Alberta (virology) and $1.25 million for the Univ of Calgary (inflammatory lung disease)....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.